Company: PACB
Filing Date: 2025-03-17
Form Type: 10-K
Source: 0001299130-25-000061
Chunk: 718

Company: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Filing Date: 2025-03-17
Form: 10-K
Item: Item 1A
Chunk 718
---
 using the following weighted-average assumptions:Years Ended December 31,202420232022Expected term in years4.94.94.6Expected volatility 81% - 93%77% - 78%70% - 76%Risk-free interest rate 3.48% – 4.32%3.73% – 4.60%0.41% – 3.66%Dividend yield ———Weighted-average grant date fair value per share$1.40 $7.32 $5.93 Cash received from option exercises for the years ended December 31, 2024, 2023, and 2022 was $1.6 million, $6.5 million and $3.4 million, respectively. 

Fiscal 2024 Form 10-K121

ESPP The fair value of shares to be issued under the ESPP was estimated using the following assumptions:Years Ended December 31,202420232022Expected term in years0.5 - 2.00.5 - 2.00.5 - 2.0Expected volatility 81% - 118%79% - 97%70% - 97%Risk-free interest rate 3.9% - 5.3%4.9% - 5.5%0.6% - 3.5%Dividend yield ———Weighted-average grant date fair value per share$1.53 $5.34 $4.28 Cash received through the ESPP for the years ended December 31, 2024, 2023, and 2022 was $6.1 million, $8.8 million, and $7.8 million, respectively.As of December 31, 2024, $80.1 million of total unrecognized compensation expense related to stock options, restricted stock, and ESPP shares was expected to be recognized over a weighted-average period of 2.2 years.

NOTE 10.  NET LOSS PER SHAREThe following table presents the calculation of the basic and diluted net loss per share amounts presented on our consolidated statements of operations and comprehensive loss: Years Ended December 31,(in thousands, except per share amounts)202420232022Numerator:BasicBasic net loss$(309,851)$(306,735)$(314,248)DilutedBasic net loss$(309,851)$(306,735)$(314,248)Add: Interest charges applicable to